| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.006 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.006 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.007 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.007 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.008 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.008 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.083 | 0.008 |